DHGF(SH:600257)2026-01-30 08:40Financial Performance - The company expects a net profit attributable to shareholders of the parent company for 2025 to be between 3.5 million and 5.5 million RMB, indicating a turnaround from a loss of 76.95 million RMB in the previous year, with a year-on-year increase of 80.45 million to 82.45 million RMB [3][4]. - The net profit attributable to shareholders after deducting non-recurring gains and losses is projected to be between -8 million and -4 million RMB, showing an improvement from a loss of 77.72 million RMB in the previous year, with a year-on-year increase of 69.72 million to 73.72 million RMB [3][4]. Subsidiary Performance - The company’s subsidiary, Hangzhou Dongfang Huakang Rehabilitation Hospital, reduced its loss from 57.28 million RMB to 33 million RMB, a decrease of 42.39% [7]. - The subsidiary, Dongfang Huakang, improved its net profit from 46.42 million RMB to 70.74 million RMB, an increase of 52.39% [7]. Receivables and Impairment - The company accelerated the collection of receivables, resulting in a 23.73% decrease in accounts receivable at the end of the reporting period compared to the beginning [7]. - Credit impairment losses decreased by 17.32 million RMB compared to the same period last year due to improved collection efforts [7]. - Asset impairment losses decreased by 26.54 million RMB, primarily due to the absence of goodwill impairment losses in the current reporting period [7]. Performance Forecast - The performance forecast is based on preliminary calculations and has not been audited by a registered accountant [8]. - There are no significant uncertainties affecting the accuracy of the performance forecast as of the announcement date [8]. - Investors are advised to pay attention to investment risks as the forecast data is preliminary and subject to change upon the release of the official annual report [10].